Huntleigh Advisors »

Oncolytics Biotech shares owned by Huntleigh Advisors

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Huntleigh Advisors from 13F filings

Historical chart of Huntleigh Advisors investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Huntleigh Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Huntleigh Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 13k 0.87

More positions owned by Huntleigh Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ab Active Etfs Short Duration H (SYFI)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amphenol Corp Cl A (APH)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Victory Portfolios Ii Core Intrmediate (UBND)
Blackrock (BLK)
Pgim Etf Tr Total Return Bon (PTRB)

View all positions for Huntleigh Advisors

Top funds holding Oncolytics Biotech

Citadel Advisors
Marshall Wace
Seeds Investor
International Assets Investment Management
Goldman Sachs Group
Connective Capital Management
XTX Topco
Virtu Financial
Tocqueville Asset Management
CIBC World Markets
Franklin Resources
Royal Bank of Canada
Geode Capital Management
Atlantic Trust
Headinvest

View all funds holding Oncolytics Biotech